ClinVar Miner

Submissions for variant NM_000171.4(GLRA1):c.705C>G (p.Phe235Leu)

dbSNP: rs1057517994
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000414290 SCV000491336 likely pathogenic not provided 2016-07-01 criteria provided, single submitter clinical testing The F235L variant in the GLRA1 gene has been reported previously in two siblings with hyperekplexia who were compound heterozygous for another missense variant (Ursitti et al., 2014). The F235L variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The F235L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species. The F235L variant is located in the disulfide bond region and strychnine-binding region of the protein. In silico analysis predicts this variant is probably damaging to the protein structure/function. The F235L variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.